Skip to content

The 2nd Matsue City Pancreatic Cancer Project

The 2nd Matsue City Pancreatic Cancer Project - The 2nd Matsue City Pancreatic Cancer Project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047799
Enrollment
300
Registered
2022-05-25
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumor

Interventions

None listed

Sponsors

Matsue Medical Association
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suspected of having pancreatic cancer due to clinical symptoms Patients with multiple risk factors for pancreatic cancer Patients whose clinical course cannot deny pancreatic cancer

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Blood tests, abdominal ultrasonography, MRI, computed tomography, endoscopic ultrasonography will be performed on symptomatic patients to confirm the frequency of pancreatic cancer detection.

Countries

Japan

Contacts

Public ContactKazuya Matsumoto

Medical corporation Irisawa Medical Clinic Internal Medicine

matsumotokazuya@tottori-u.ac.jp0852-38-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026